Virksomheden, der fremstiller Herceptin, skal gennemføre flere undersøgelser af kardiotoksiciteten og bl. a. undersøge den vejledning, der gives til læger, samt hvordan patienter med risiko for hjerteproblemer kan identificeres for at sikre, at de overvåges nøje.
The company that makes Herceptin will carry out more studies looking at cardiotoxicity, including looking at the guidance supplied to doctors and how to identify patients at risk of heart problems to ensure that they are carefully monitored.